Fu Qiang, Wu Yili
Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Department of Psychiatry, Jining Medical University, Jining, Shandong, China.
Oncotarget. 2017 Dec 11;9(1):54-66. doi: 10.18632/oncotarget.23094. eCollection 2018 Jan 2.
The inverse association between Alzheimer's disease (AD) and cancer has been reported in several population-based studies although both of them are age-related disorders. However, molecular mechanisms of the inverse association remain elusive. Increased expression of regulator of calcineurin 1 (RCAN1) promotes the pathogenesis of AD, while it suppresses cancer growth and progression in many types of cancer. Moreover, aberrant RCAN1 expression is detected in both AD and various types of cancer. It suggests that RCAN1 may play a key role in the inverse association between AD and cancer. In this article, we aim to review the role of RCAN1 in the inverse association and discuss underlying mechanisms, providing an insight into developing a novel approach to treat AD and cancer.
尽管阿尔茨海默病(AD)和癌症都是与年龄相关的疾病,但多项基于人群的研究报告了它们之间的负相关关系。然而,这种负相关关系的分子机制仍然不清楚。钙调神经磷酸酶1调节因子(RCAN1)表达增加会促进AD的发病机制,而在多种癌症中它会抑制癌症的生长和进展。此外,在AD和各种类型的癌症中都检测到了RCAN1的异常表达。这表明RCAN1可能在AD和癌症之间的负相关关系中起关键作用。在本文中,我们旨在综述RCAN1在这种负相关关系中的作用,并讨论潜在机制,为开发治疗AD和癌症的新方法提供思路。